On October 6, 2017, the Forum for Collaborative Research will convene the 4th CMV in Transplantation Settings Meeting in San Diego, CA. The goal of the CMV Forum is to advance the regulatory sciences for the treatment and management of CMV by providing an independent and neutral venue for ongoing multi-stakeholder dialogue.
Materials
Presentations
- Overview and Introductions
Veronica Miller, Forum for Collaborative Research - Regulatory Updates: FDA
Mary Singer, U.S. Food and Drug Administration - CMV DNAaemia: Planned Analysis
Michael Boeckh, University of Washington - Industry Updates:
Garrett Nichols, Chimerix, Inc.
Cyrus Badshah, Merck
Obi Umeh, Shire - The CMV Refractory and Resistant Disease Definition Working Group
Roy Chemaly, UT MD Anderson Cancer Center
Sunwen Chou, Oregon Health & Science University